Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Egfr Nsclc'

Egfr Nsclc published presentations and documents on DocSlides.

A brief overview of CKD

A brief overview of CKD

  • sadie
  • 37 Slides

Harshani D. Perera . Senior Registrar – Nephrolo...

Multidisciplinary approach to lung cancer

Multidisciplinary approach to lung cancer

  • elena
  • 65 Slides

Kamil Konopka. Department of Oncology, University ...

Checkpoint inhibitors for

Checkpoint inhibitors for

  • paisley
  • 53 Slides

NSCLC. An update. Solange Peters, MD-PhD. Oncology...

Updates in the systemic treatment for lung

Updates in the systemic treatment for lung

  • madeline
  • 57 Slides

cancer: Immunotherapy. Oscar Arrieta MD. Thoracic....

Webinar: Importance of Reporting Adverse Events to SAHPRA

Webinar: Importance of Reporting Adverse Events to SAHPRA

  • jocelyn
  • 9 Slides

. JHB Health . District . 27. th. September. . 2...

Clinical Controversies: Recent Updates for Medication Use in Chronic Kidney Disease

Clinical Controversies: Recent Updates for Medication Use in Chronic Kidney Disease

  • amey
  • 51 Slides

Tracy Anderson-Haag, . PharmD. , BCPS. Clinical Ph...

FIRST-LINE EGFRm+ NSCLC PATIENT CASE STUDY

FIRST-LINE EGFRm+ NSCLC PATIENT CASE STUDY

  • pamela
  • 12 Slides

Case study 9. Provided by . Dr Qamar Ghafoor, Clin...

MET receptor inhibition

MET receptor inhibition

  • emma
  • 42 Slides

in . solid. . tumors. Roberto Bianco. Università...

Treatment in Advanced Non-Small Cell Lung Cancer

Treatment in Advanced Non-Small Cell Lung Cancer

  • oconnor
  • 49 Slides

. 5. th. most commonly diagnosed cancer in Austra...

CLINICAL EXPERIENCE OF NSCLC in RSDM

CLINICAL EXPERIENCE OF NSCLC in RSDM

  • sophia
  • 48 Slides

Ana Rima. PENDAHULUAN. 2. Kanker Paru. P. enyebab ...

Consensus or Controversy?  

Consensus or Controversy?  

  • okelly
  • 109 Slides

Addressing Practical Clinical Questions Across the...

New developments in oncological treatment for Stage 3 NSCLC

New developments in oncological treatment for Stage 3 NSCLC

  • summer
  • 13 Slides

Lung SSG 22. nd. May 2018. Gareth Ayre. Rationale...

Anti-EGFR induced skin

Anti-EGFR induced skin

  • berey
  • 15 Slides

toxicity. ESDO Learning Bytes 2021. Dr Violaine RA...

Istituto Toscano Tumori –Livorno, Italy

Istituto Toscano Tumori –Livorno, Italy

  • payton
  • 32 Slides

Federico . Cappuzzo. Istituto Toscano Tumori. Ospe...

The 1,2,3 of CKD W.A. Wilmer, MD

The 1,2,3 of CKD W.A. Wilmer, MD

  • layla
  • 63 Slides

Kidney Specialists, Inc.. National Kidney Foundati...

Second line treatments in WT

Second line treatments in WT

  • deena
  • 56 Slides

pts. : . which. . opportunities. with . biologic...

Roberto Bianco Laboratori di Terapia Molecolare dei Tumori

Roberto Bianco Laboratori di Terapia Molecolare dei Tumori

  • finley
  • 39 Slides

Università . di Napoli “Federico II”. Innovat...

Prise en charge des patients

Prise en charge des patients

  • ethlyn
  • 21 Slides

insuffisants cardiaques ET insuffisants rénaux :....

Pharmacometrics and Biostatistics Interactions at the FDA

Pharmacometrics and Biostatistics Interactions at the FDA

  • byrne
  • 29 Slides

Jeffry Florian, Ph.D.. Division of Pharmacometrics...

Striving for Consensus on the

Striving for Consensus on the

  • samantha
  • 52 Slides

Optimal Management of Metastatic . Non-Small Cell ...

NefIgArd Barratt et al.

NefIgArd Barratt et al.

  • miller
  • 3 Slides

RASi. + Placebo. vs. RASi. + Budesonide. Nefecon...

Way of the Wizard: Deploying

Way of the Wizard: Deploying

  • jainy
  • 39 Slides

Genomics in Pathology for Precision Medicine in Ca...

The Effect of Semaglutide on Kidney Function: Post-Hoc Analysis of Three Randomized Controlled Tria

The Effect of Semaglutide on Kidney Function: Post-Hoc Analysis of Three Randomized Controlled Tria

  • berey
  • 8 Slides

Metabolic Dysfunction-Associated Steatotic Liver D...

The formula Blueprint Medicines (BPMC)

The formula Blueprint Medicines (BPMC)

  • erica
  • 14 Slides

The sum of Blueprint’s pieces exceeds current va...

Phase II studies of Nivolumab

Phase II studies of Nivolumab

  • brianna
  • 5 Slides

in patients with Advanced . Squamous. (SQ) or Non...

Sodium-glucose link transporter-2 inhibitors in reduced renal function: Cross-class comparison from

Sodium-glucose link transporter-2 inhibitors in reduced renal function: Cross-class comparison from

  • blanko
  • 10 Slides

TSJ Crabtree. 1. , A Bickerton. 2. , K Dhatariya. ...

METHODS Conclusion INTRODUCTION

METHODS Conclusion INTRODUCTION

  • anderson
  • 1 Slides

ACKNOWLEDGEMENTS. REFERENCES. Leslie . Dunc...

SW GLH services for NSCLC – An update

SW GLH services for NSCLC – An update

  • everly
  • 14 Slides

Professor Rachel Butler. The genomic complexity of...

Targeting EGFR Exon 20 insertions

Targeting EGFR Exon 20 insertions

  • unita
  • 26 Slides

Gregory J. Riely. November 2021. What about those ...

LIFE Study: Lower Systolic Pressure Slowed Progression of Renal Dysfunction

LIFE Study: Lower Systolic Pressure Slowed Progression of Renal Dysfunction

  • tracy
  • 7 Slides

in . Hypertension. From ESH 2016 | POS 4C:. Sverre...

Priorities for Type 2 Diabetes

Priorities for Type 2 Diabetes

  • griffin
  • 27 Slides

Dr Kashif ali . dr. . james. . boyle. Prim...

Safety of Tenofovir

Safety of Tenofovir

  • deandre922
  • 23 Slides

Alafenamide. in Renal Impairment. A Pozniak. 1. ,...

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

  • sawyer742
  • 5 Slides

Intervista a Federico . Cappuzzo. Background:. Pr...

INTRODUCTION RESULTS

INTRODUCTION RESULTS

  • arjun383
  • 1 Slides

Mason Alford, MSc. a. , . Candace J. Grisham, MS. ...

Renal function in the PROUD study, a pragmatic open label randomised trial of

Renal function in the PROUD study, a pragmatic open label randomised trial of

  • grady822
  • 16 Slides

Truvada. as pre-exposure prophylaxis. Iain Reeves...

North Bristol Quality Improvement Evans Transplant Taylor Turner

North Bristol Quality Improvement Evans Transplant Taylor Turner

  • easton
  • 15 Slides

Diane Evans, Transplant Coordinator. Dominic Taylo...

Cases from the Clinic(ians): Case-based Panel Discussion

Cases from the Clinic(ians): Case-based Panel Discussion

  • tripp
  • 15 Slides

Associate Dean for Global Health. University of Al...

Glomerular Filtration Rate, Chronic Kidney Disease, and Transplant Eligibility

Glomerular Filtration Rate, Chronic Kidney Disease, and Transplant Eligibility

  • kaiden438
  • 4 Slides

Assumed background knowledge: basic nephron physio...

Lung Tumors

Lung Tumors

  • lorenzo155
  • 44 Slides

4/1/24. Michael Forte, MD. Outline . Lung Cancer ...

Copyright © 2024 DocSlides. All Rights Reserved